BC
OCDX

Brookfield Corp’s Ortho Clinical Diagnostics Holdings plc Ordinary Shares OCDX Stock Holding History

Brookfield Corp’s Portfolio OCDX Stock Details OCDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-70,000
Closed -$1.5M – 834
2021
Q4 		$1.5M Sell
70,000
-514,101
-88% -$10.1M 0.01% 380
2021
Q3 		$10.8M Buy
584,101
+358,644
+159% +$7.22M 0.04% 130
2021
Q2 		$4.83M Sell
225,457
-229,589
-50% -$4.67M 0.02% 223
2021
Q1 		$8.78M Buy
+455,046
New +$8.02M 0.04% 124

Other funds holding OCDX

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
VI
Versor Investments New York $47.5M AUM 100.43% 1-Year Est. Return
SCM
Shapiro Capital Management Atlanta, Georgia $1.65B AUM 26.74% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $11B AUM 3.37% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return

Brookfield Corp's OCDX Position: Q1 2022 in Review

Brookfield Corp sold out of Ortho Clinical Diagnostics Holdings plc Ordinary Shares (OCDX) in Q1 2022, closing a stake of 70,000 shares — an estimated $1.5M sold.

Brookfield Corp first reported a position in OCDX in Q1 2021 and held it in 4 quarters. The position peaked at $10.8M in Q3 2021. 170 funds tracked by Wall St. Rank hold OCDX as of Q1 2022.

  • Brookfield Corp reported no remaining Ortho Clinical Diagnostics Holdings plc Ordinary Shares position as of Q1 2022 after selling out during the quarter.
  • Brookfield Corp sold 70,000 Ortho Clinical Diagnostics Holdings plc Ordinary Shares shares in Q1 2022, an estimated $1.5M.
  • Brookfield Corp first reported a position in Ortho Clinical Diagnostics Holdings plc Ordinary Shares in Q1 2021 and held it in 4 quarters.
  • Brookfield Corp's Ortho Clinical Diagnostics Holdings plc Ordinary Shares position peaked at $10.8M in Q3 2021.
  • 170 funds tracked by Wall St. Rank held Ortho Clinical Diagnostics Holdings plc Ordinary Shares as of Q1 2022.

Based on Brookfield Corp's 13F filing for Q1 2022, filed 16 May 2022.